DIAGNOS (CVE:ADK) Director Acquires C$50,400.00 in Stock

DIAGNOS Inc. (CVE:ADK) Director Robert Dunn acquired 105,000 shares of the business’s stock in a transaction dated Friday, August 28th. The shares were purchased at an average price of C$0.48 per share, with a total value of C$50,400.00. Following the transaction, the director owned 2,679,920 shares of the company’s stock, valued at approximately C$1,286,361.60. This represents a 4.08% increase in their ownership of the stock.

Robert Dunn also recently made the following trade(s):

• On Wednesday, July 29th, Robert Dunn bought 200,000 shares of DIAGNOS stock. The stock was purchased at an average price of C$0.30 per share, for a total transaction of C$60,000.00.

DIAGNOS Price Performance

Shares of DIAGNOS stock opened at C$0.50 on Monday. The firm has a market cap of C$60.21 million, a PE ratio of -12.50 and a beta of -0.14. The stock has a 50 day moving average of C$0.30 and a 200 day moving average of C$0.27. The company has a current ratio of 1.49, a quick ratio of 0.68 and a debt-to-equity ratio of 204.05. DIAGNOS Inc. has a 12 month low of C$0.17 and a 12 month high of C$0.52.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.